Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

kohlpharma gmbh (3216120) - ramipril - tablette - ramipril (22686) 2,5 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

mpa pharma gmbh (3180474) - ramipril - tablette - ramipril (22686) 2,5 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

kohlpharma gmbh (3216120) - enalaprilmaleat; lercanidipinhydrochlorid - filmtablette - 20 mg/10 mg - teil 1 - filmtablette; enalaprilmaleat (23100) 20 milligramm; lercanidipinhydrochlorid (24911) 10 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

kohlpharma gmbh (3216120) - enalaprilmaleat; lercanidipinhydrochlorid - filmtablette - 10 mg/10 mg - teil 1 - filmtablette; enalaprilmaleat (23100) 10 milligramm; lercanidipinhydrochlorid (24911) 10 milligramm

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

gynial gmbh - cyproteron acetat; ethinylestradiol - cyproteron und estrogen

Europäische Union - Deutsch - EMA (European Medicines Agency)

accord healthcare s.l.u. - lacosamid - epilepsie - antiepileptika, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

gynial gmbh - dienogest -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

gynial gmbh - ethinylestradiol; levonorgestrel -

Europäische Union - Deutsch - EMA (European Medicines Agency)

extrovis eu ltd. - lacosamid - epilepsie - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Europäische Union - Deutsch - EMA (European Medicines Agency)

zentiva, k.s. - pregabalin - anxiety disorders; epilepsy - antiepileptika, - neuropathic pain , pregabalin zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , epilepsy , pregabalin zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , generalised anxiety disorder , pregabalin zentiva is indicated for the treatment of generalised anxiety disorder (gad) in adults.